Yoshihisa Nasa Selected Research

sampatrilat

4/2003

Beneficial effects of sampatrilat, a novel vasopeptidase inhibitor, on cardiac remodeling and function of rats with chronic heart failure following left coronary artery ligation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshihisa Nasa Research Topics

Disease

2	Hypertension (High Blood Pressure) 07/2010 - 03/2005
2	Hypotension (Low Blood Pressure) 03/2007 - 03/2002
2	Heart Failure 12/2003 - 04/2003
2	Fibrosis (Cirrhosis) 12/2003 - 04/2003
1	Bradycardia 03/2007
1	Tachycardia (Tachyarrhythmias) 03/2007
1	AIDS-Related Complex (ARC) 03/2007
1	Shock 05/2006
1	Cardiomegaly (Heart Hypertrophy) 12/2003

Drug/Important Bio-Agent (IBA)

2	SaltsIBA 07/2010 - 03/2005
2	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 07/2010 - 03/2007
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 03/2007 - 03/2002
2	Vasopeptidase InhibitorsIBA 12/2003 - 04/2003
1	Urethane (Ethyl Carbamate)IBA 03/2007
1	Adrenergic Agents (Adrenergic Drugs)IBA 03/2007
1	Cholinergic Agents (Cholinergics)IBA 03/2007
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 03/2007
1	Vasoconstrictor AgentsIBA 05/2006
1	Vasopressins (Vasopressin)IBA 05/2006
1	CatecholaminesIBA 03/2005
1	CollagenIBA 12/2003
1	Neprilysin (Neutral Endopeptidase)IBA 12/2003
1	omapatrilatIBA 12/2003
1	Natriuretic PeptidesIBA 04/2003
1	sampatrilatIBA 04/2003
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2003
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2003
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2002

Therapy/Procedure

1	Anesthesia 03/2007
1	Ligation 04/2003